The purpose of the study is to assess safety and tolerability of AZD9819 following inhaled administration of single and multiple increasing doses, and to estimate the maximum dose that is tolerated in healthy people.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Enrollment
100
Research Site
London, United Kingdom
Safety variables (ECG variables, adverse events, blood pressure, pulse, body temp, safety lab)
Time frame: Frequent safety measurements during the study from screening period to follow-up
Pharmacokinetic variables of AZD9819 by assessment of drug concentrations in plasma
Time frame: Multiple PK blood samples from pre-dose until 96 hours post last dose
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.